Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma

  1. Pro, B.
  2. Horwitz, S.M.
  3. Prince, H.M.
  4. Foss, F.M.
  5. Sokol, L.
  6. Greenwood, M.
  7. Caballero, D.
  8. Morschhauser, F.
  9. Wilhelm, M.
  10. Iyer, S.P.
  11. Shustov, A.R.
  12. Wolfson, J.
  13. Balser, B.E.
  14. Coiffier, B.
Aldizkaria:
Hematological Oncology

ISSN: 1099-1069,  0278-0232

Argitalpen urtea: 2017

Alea: 35

Zenbakia: 4

Orrialdeak: 914-917

Mota: Gutuna

DOI: 10.1002/HON.2320 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus